Clinical Profile and Cardiovascular Risk Factors Among Hemophilians Followed at University Clinics of Kinshasa
Gueth Kundabi,
Gibency Mfulani,
Karim Assani,
Nina Domo,
Aleine Budiongo,
Jonathan Kukila,
Eric Mukenge,
John Senga,
Bodi Mabiala,
René Ngiyulu,
Jean-Lambert Gini
Issue:
Volume 9, Issue 3, June 2023
Pages:
28-37
Received:
11 June 2023
Accepted:
11 July 2023
Published:
31 August 2023
Abstract: Background: Hemophilia is a congenital, inherited bleeding disorder that prevents blood from clotting, causing abnormally long bleeding. It remains underdiagnosed in Africa and particularly in the Democratic Republic of Congo, where it remains poorly known to the population and health professionals. The present study aims to determine the clinical profile and cardiovascular risk factors in hemophiliacs at the University Clinics of Kinshasa. Methods: This is a cross-sectional study with an analytical aim, in which 155 patients (children and adults) with a haemorrhagic syndrome were included. The diagnosis of haemophilia was confirmed in thirty-six patients, all male; 22 hemophiliac patients regularly followed were matched with 24 non-hemophilic patients (control group). Results: hemophilia A represented 81% and hemophilia B 19%. The most represented age group was between 3 to 6 years (19%). Regarding the severity of the disease, half of the patients, or 50%, presented with severe hemophilia, the main symptom being hemarthrosis (30%). Of our total sample of hemophiliacs, we had recorded two cases of death (5.5%). Regarding cardiovascular risk factors, only the deterioration of myocardial function was found in one patient (4.5%). Conclusion: hemophilia is a disabling disease, which alters the quality of life of patients. Cardiovascular risk factors seem to be lower in Congolese hemophiliacs, however, ultrasound monitoring is necessary in order to prevent any pejorative evolution.
Abstract: Background: Hemophilia is a congenital, inherited bleeding disorder that prevents blood from clotting, causing abnormally long bleeding. It remains underdiagnosed in Africa and particularly in the Democratic Republic of Congo, where it remains poorly known to the population and health professionals. The present study aims to determine the clinical ...
Show More
Combined Antibacterial Effect of Croton macrostachyus, Calpurina aurea and Ocimum gratissimum Against Selected Clinical and Standard Pathogenic Bacteria
Ayichew Teshale,
Nega Berhane,
Wagaw Sendeku
Issue:
Volume 9, Issue 3, June 2023
Pages:
38-46
Received:
17 February 2023
Accepted:
11 July 2023
Published:
13 September 2023
Abstract: Background: The use of medicinal plants as treatment options of human and animal diseases can be traced back in human history, and about ten percent of identified medicinal plants serve a pharmaceutical role because they have active chemical constituents such phenolic acids, flavonoids, tannins and lignin. Ethiopia is a place rich in medicinal plants, though most studies in the region have only considered the individual effects of their extracts while under-exploring their combined effects. Objective: The objective of this research was to assess the synergistic antibacterial activity of crude extracts of leaves of Croton macrostachyus, Calpurnia aurea and Ocimum gratissimum collected from Bahir Dar town against standard and clinical isolates of Staphylococcus aureus, Escherichia coli and Salmonella typhi by using methanol, acetone and chloroform as solvents. Methods: Extracts were prepared at a plant-to-solvent ratio of 50 g to 500 mL and then set to a concentration of 50 mg/mL by dissolving 100 mg of crude extract in 2 ml of 10% dimethyl sulfoxide in small cups, from which 100 µL was used for antibacterial assays using the disc diffusion method. Minimum inhibitory and bactericidal concentration assays were assessed with the broth microdilution and overnight bacterial culture preparation techniques, respectively. The fractional inhibitory concentration index was used for synergistic activity analysis. Results: Combinations of extracts showed relatively better effects against most test bacteria with inhibition zones reaching up to 23.00 ± 1.00 mm (Salmonella typhi) despite limited activity on both standard and clinical isolates of Escherichia coli. The lowermost minimum inhibitory and bactericidal concentrations were 3.125 mg/mL and 6.25 mg/mL, respectively, and a few synergistic and many additive effects were recorded for different forms of combinations on different bacterial isolates. Conclusion: The combined use of extracts is relatively promising, though further work is required to clearly set the safety margins of combinations used in vivo, as this is the first report on all settings used here. The findings of this study provide scientific evidence for communities, pharmaceutical industries, and other concerned bodies regarding alternative formulations of phytochemicals for the relief of different physiological deviations, with the combined use of plants showing better performance.
Abstract: Background: The use of medicinal plants as treatment options of human and animal diseases can be traced back in human history, and about ten percent of identified medicinal plants serve a pharmaceutical role because they have active chemical constituents such phenolic acids, flavonoids, tannins and lignin. Ethiopia is a place rich in medicinal plan...
Show More
